In 2018 Avalon Pharma showed a growth rate of 5.9% relative to a market decline of -1.5%.
In 2018 Avalon Pharma grew to becoming the 13th largest pharmaceutical company in the Kingdom
The key aspects of Avalon Pharma’s governance are integrity, sustainable business practices, customer focused outlook, and strong leadership to manage a high-growth working environment Avalon Pharma is a process driven corporation that is able to execute projects via faster decision-making. Company is managed by the Executive Committee with constant guidance from the Board of Directors. Responsibilities are defined, and cross-functional interactions are encouraged for effective governance.